Abstract
We report that the tumor neurosis factor homolog APRIL (a proliferation-inducing ligand) stimulates in vitro proliferation of primary B and T cells and increases spleen weight due to accumulation of B cells in vivo. APRIL functions via binding to BCMA (B cell maturation antigen) and TACI (transmembrane activator and CAML-interactor) and competes with TALL-1 (also called BLyS or BAFF) for receptor binding. Soluble BCMA and TACI specifically prevent binding of APRIL and block APRIL-stimulated proliferation of primary B cells. BCMA-Fc also inhibits production of antibodies against keyhole limpet hemocyanin and Pneumovax in mice, indicating that APRIL and/or TALL-1 signaling via BCMA and/or TACI are required for generation of humoral immunity. Thus, APRIL–TALL-1 and BCMA-TACI form a two ligands–two receptors pathway involved in stimulation of B and T cell function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hahne, M. et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188, 1185 –1190 (1998).
Anderson, D. M. et al. A homolog of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175–179 (1997).
Chinnaiyan, A. M. et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990–992 (1996).
Chicheportiche, Y. et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272, 32401–32410 (1997).
Khare, S. D. et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl Acad. Sci. USA 97, 3370–3375 (2000).
Moore, P. A. et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260– 263 (1999).
Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309 –319 (1997)
Frade, J. M., Rodriguez, T. A. & Barde, Y. A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166–168 (1996).
Smith, C. A., Farrah, T. & Goodwin, R.G. The TNF receptor superfamily of cellular and viral protein: activation,costimulation, and death. Cell 76, 959–962 (1994).
Screaton, G. & Xu, X. T cell life and death signalling via TNF-receptor family members. Curr. Opin. Immunol. 12 , 316–322 (2000).
Kelly, K., Manos, E., Jensen, G., Nadauld, L. & Jones D. A. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 60, 1021– 1027 (2000).
Bucher, P., Karplus. K., Moeri, N & Hofmann, K. A flexible motif search technique based on generalized profiles. Comput. Chem. 20, 3–23 (1996).
Shu, H. B., Hu. W. H. & Johnson, H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 65, 680– 683 (1999).
von Bulow, G. U. & Bram, R. J. NF-AT activation induced by a CAML-eracting member of the tumor necrosis factor receptor superfamily . Science 278, 138–141 (1997).
Laabi, Y., Gras. M., Brouet, J. C., Berger, R., Larsen, C. J. & Tsapis, A. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res. 22, 1147 –1154 (1994).
Madry, C. et al. The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. Int. Immunol. 10, 1693–1702 ( 1998).
Schneider, P. et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747–1756 (1999).
Xia, X. Z. et al. TACI is a TRAF-interacting receptor for TALL-1, a Tumor Necrosis Factor family member involved in B cell regulation. J. Exp. Med. 192, 137–143 ( 2000).
Gross, J. A. et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995–999 (2000).
Sheridan, J. P. et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818– 821 (1997).
Lamam, J. D. & Claassen, E. T-Cell-Independent and T-Cell-Dependent Humoral Immunity (ed. CM, S.) (John Wiley & Sons, New York, 1996).
Dubois, B. et al. Dendritic Cells Enhance Growth and Differentiation of CD40-activated B Lymphocytes. J. Exp. Med. 185, 941– 951 (1997).
Kooten, C. & Banchereau, J. CD40-CD40 ligand. J. Leukoc. Bio. 67, 2–17. (2000).
Armitage, R. J. & Alderson, M. R. B-cell stimulation . Curr. Opin. Immunol. 7, 243– 247. (1995).
Shanebeck, K. D. et al. Regulation of murine B cell growth and differentiation by CD30 ligand. Eur. J. Immunol. 25, 2147– 2153 (1995).
Marsters, S. A. et al. Interactionof the TNF homologues BlyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10, 785–788 (2000).
Nakayama, K. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327, 625–635 (1997).
Hatzoglou, A. et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165, 1322– 1330 (2000).
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Yu, G., Boone, T., Delaney, J. et al. APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol 1, 252–256 (2000). https://doi.org/10.1038/79802
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/79802
This article is cited by
-
Alpha-Fetoprotein as a Factor of Differentiation and Functional Activity of Myeloid-Derived Suppressor Cells
Bulletin of Experimental Biology and Medicine (2023)
-
B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages
Journal of Translational Medicine (2022)
-
Monitoring of Soluble Forms of BAFF System (BAFF, APRIL, sR-BAFF, sTACI and sBCMA) in Kidney Transplantation
Archivum Immunologiae et Therapiae Experimentalis (2022)
-
Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview
Autoimmunity Highlights (2021)
-
Targeting co-stimulatory molecules in autoimmune disease
Nature Reviews Drug Discovery (2020)